Literature DB >> 11756777

Familial adenomatous polyposis associated with multiple endocrine neoplasia type 1-related tumors and thyroid carcinoma: a case report with clinicopathologic and molecular analyses.

Yuzo Sakai1, Koich Koizumi, Iwao Sugitani, Ken Nakagawa, Masami Arai, Joji Utsunomiya, Tetsuichiro Muto, Rikiya Fujita, Yo Kato.   

Abstract

We describe a sporadic case with familial adenomatous polyposis, multiple endocrine neoplasia type 1 (MEN1)-related tumors (an endocrine cell tumor of the pancreas and bilateral parathyroid tumors), and a papillary thyroid carcinoma. To clarify how mutations of the adenomatous polyposis coli ( APC ) gene and the MEN1 gene, responsible for familial adenomatous polyposis and MEN1, respectively, might have contributed to tumorigenesis in this case, we studied germline mutations in both genes and loss of heterozygosity at their genetic loci in multiple lesions. In addition, we performed immunohistochemistry for beta-catenin, associated with the function of the APC gene. A germline mutation was found in the APC gene but not in the MEN1 gene. Normal allelic loss at the APC gene locus was observed in bilateral parathyroid tumors. Immunohistochemical staining of beta-catenin demonstrated accumulation in the cytoplasm in addition to membrane staining in all analyzed tumors and a strong nuclear reaction in the endocrine cell tumor of the pancreas. The presence of normal allelic deletions of the APC gene in bilateral parathyroid tumors and nuclear staining of beta-catenin in the pancreatic tumor in addition to the germline mutations suggests that functional loss of the APC gene played an important role not only in familial adenomatous polyposis but also in the MEN1-related tumors in this case.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756777     DOI: 10.1097/00000478-200201000-00014

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  6 in total

1.  Whole exome sequencing in familial isolated primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; P Aretini; F Saponaro; S Borsari; L Mazoni; M Apicella; P Civita; M La Ferla; M A Caligo; F Lessi; C M Mazzanti; L Torregossa; A Oppo; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-09-05       Impact factor: 4.256

2.  Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes.

Authors:  Adam Andreasson; Luqman Sulaiman; Sónia do Vale; João Martin Martins; Florbela Ferreira; Gabriel Miltenberger-Miltenyi; Lucas Batista; Felix Haglund; Erik Björck; Inga-Lena Nilsson; Anders Höög; Catharina Larsson; C Christofer Juhlin
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Case of Recurrent Primary Hyperparathyroidism, Congenital Granular Cell Tumor, and Aggressive Colorectal Cancer.

Authors:  Samina Afreen; Lee S Weinstein; William F Simonds; Smita Jha
Journal:  J Endocr Soc       Date:  2022-06-24

Review 4.  Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.

Authors:  Hye-Sun Park; Yeon Hee Lee; Namki Hong; Dongju Won; Yumie Rhee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

Review 5.  Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

Review 6.  Parathyroid Imaging: Past, Present, and Future.

Authors:  Michael A Morris; Babak Saboury; Mark Ahlman; Ashkan A Malayeri; Elizabeth C Jones; Clara C Chen; Corina Millo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-25       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.